MetaCap

Axonex AI Group Limited Class A Company Profile

NASDAQ: AXNXConsumer DiscretionaryBusiness ServicesUSD

0.8301-0.0749 (-8.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Axonex AI Group at a glance

Axonex AI Group Limited Class A (NASDAQ: AXNX) is a Business Services company in the Consumer Discretionary sector headquartered in Irvine, CA, Hong Kong. Axonex AI Group is led by Mr. Raymond W. Cohen and employs about 797 people. The company's shares have traded publicly since 2025.

At a market capitalization of $5.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001998560, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Axonex AI Group do?

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. As of November 15, 2024, Axonics, Inc. operates as a subsidiary of Boston Scientific Corporation.

Business description based on the company's public filings.

Company information

Legal name
Axonex AI Group Limited Class A
Ticker
NASDAQ: AXNX
Industry
Business Services
CEO
Mr. Raymond W. Cohen
Employees
797
Headquarters
26 Technology Drive, Irvine, CA, Hong Kong
Phone
949 396 6322
IPO year
2025
SEC CIK
0001998560

Companies similar to Axonex AI Group

AXNX peer companies
CompanyPrice% ChgMarket capCompare
KRKR36Kr Holdings Inc. ADR2.56-3.40%$5.05Mvs AXNX
BAOSBaosheng Media Group Holdings Limited0.1166-8.91%$3.89Mvs AXNX
OLBThe OLB Group Inc.0.115-4.33%$3.59Mvs AXNX
TGLTreasure Global Inc.3.88-5.13%$3.56Mvs AXNX
CJMBCallan JMB Inc.0.301-7.10%$3.21Mvs AXNX
QHQuhuo Limited Class A3.06-1.29%$8.42Mvs AXNX
UKUcommune International Ltd Class A1.10-9.84%$745.75Kvs AXNX
XHLDTEN Holdings Inc.0.6402-3.03%$9.90Mvs AXNX

Related